Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anastasios Maniakas

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Head & Neck|September 2, 2025
Management of Retropharyngeal Lymph Node Metastases in Thyroid CancerIsabelle Fournier, Ashwini Venkata Bandi, Sarah Hamidi, et al.
Head & Neck|October 8, 2025
Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and SurvivalAnastasios Maniakas, David C Wilde, Isabelle Fournier, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 30, 2026
A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown PrimaryThomas G Townes, Julian Martinez, Neil D Gross, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort StudyXiao Zhao, Jennifer Rui Wang, Ramona Dadu, et al.
JCO Precision Oncology|February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2024
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancerJulianna K Bronk, Alexander Augustyn, Abdallah S R Mohamed, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2026
Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic <i>BRAF</i> Wild-Type Anaplastic Thyroid CarcinomaSarah Hamidi, Danica M Vodopivec, Naifa L Busaidy, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenuesSarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Head & Neck|September 2, 2025
Management of Retropharyngeal Lymph Node Metastases in Thyroid CancerIsabelle Fournier, Ashwini Venkata Bandi, Sarah Hamidi, et al.
Head & Neck|October 8, 2025
Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and SurvivalAnastasios Maniakas, David C Wilde, Isabelle Fournier, et al.
The Journal of Clinical Endocrinology and Metabolism|June 13, 2021
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid CarcinomaYing C Henderson, Abdallah S R Mohamed, Anastasios Maniakas, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 30, 2026
A Standardized Algorithm's Impact on Primary Detection in Head and Neck Carcinoma of Unknown PrimaryThomas G Townes, Julian Martinez, Neil D Gross, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF<sup>V600E</sup> Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort StudyXiao Zhao, Jennifer Rui Wang, Ramona Dadu, et al.
JCO Precision Oncology|February 21, 2025
<i>NTRK</i> Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted TherapyVicente R Marczyk, Sasan Fazeli, Ramona Dadu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2024
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancerJulianna K Bronk, Alexander Augustyn, Abdallah S R Mohamed, et al.
Thyroid : Official Journal of the American Thyroid Association|March 6, 2026
Real-World Experience with Lenvatinib plus Pembrolizumab in Metastatic <i>BRAF</i> Wild-Type Anaplastic Thyroid CarcinomaSarah Hamidi, Danica M Vodopivec, Naifa L Busaidy, et al.
The Journal of Clinical Endocrinology and Metabolism|June 26, 2025
Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenuesSarah Hamidi, Anastasios Maniakas, Neal S Akhave, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cellsJerry H Houl, Rozita Bagheri-Yarmand, Muthusamy Kunnimalaiyaan, et al.
Pageof 7